CVE-2017-17677
BMC Remedy BIRT Code Execution Vulnerability
Description
BMC Remedy 9.1SP3 is affected by authenticated code execution. Authenticated users that have the right to create reports can use BIRT templates to run code.
INFO
Published Date :
May 19, 2021, 2:15 p.m.
Last Modified :
June 1, 2021, 5:29 p.m.
Source :
[email protected]
Remotely Exploitable :
Yes !
Impact Score :
5.9
Exploitability Score :
2.8
References to Advisories, Solutions, and Tools
Here, you will find a curated list of external links that provide in-depth
information, practical solutions, and valuable tools related to
CVE-2017-17677.
| URL | Resource |
|---|---|
| http://bmc.com | Product |
| http://remedy.com | Product |
| https://docs.bmc.com/docs/ars91/en/9-1-00-fixes-available-for-remedy-ar-system-security-vulnerabilities-800555806.html | Release Notes Vendor Advisory |
| https://seclists.org/fulldisclosure/2017/Oct/52 | Mailing List Third Party Advisory |
We scan GitHub repositories to detect new proof-of-concept exploits. Following list is a collection of public exploits and proof-of-concepts, which have been published on GitHub (sorted by the most recently updated).
Results are limited to the first 15 repositories due to potential performance issues.
The following list is the news that have been mention
CVE-2017-17677 vulnerability anywhere in the article.
The following table lists the changes that have been made to the
CVE-2017-17677 vulnerability over time.
Vulnerability history details can be useful for understanding the evolution of a vulnerability, and for identifying the most recent changes that may impact the vulnerability's severity, exploitability, or other characteristics.
-
CVE Modified by [email protected]
May. 14, 2024
Action Type Old Value New Value -
Initial Analysis by [email protected]
Jun. 01, 2021
Action Type Old Value New Value Added CVSS V2 NIST (AV:N/AC:L/Au:S/C:P/I:P/A:P) Added CVSS V3.1 NIST AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H Changed Reference Type http://bmc.com No Types Assigned http://bmc.com Product Changed Reference Type http://remedy.com No Types Assigned http://remedy.com Product Changed Reference Type https://docs.bmc.com/docs/ars91/en/9-1-00-fixes-available-for-remedy-ar-system-security-vulnerabilities-800555806.html No Types Assigned https://docs.bmc.com/docs/ars91/en/9-1-00-fixes-available-for-remedy-ar-system-security-vulnerabilities-800555806.html Release Notes, Vendor Advisory Changed Reference Type https://seclists.org/fulldisclosure/2017/Oct/52 No Types Assigned https://seclists.org/fulldisclosure/2017/Oct/52 Mailing List, Third Party Advisory Added CWE NIST CWE-732 Added CPE Configuration OR *cpe:2.3:a:bmc:remedy_mid-tier:9.1:sp3:*:*:*:*:*:*
CWE - Common Weakness Enumeration
While CVE identifies
specific instances of vulnerabilities, CWE categorizes the common flaws or
weaknesses that can lead to vulnerabilities. CVE-2017-17677 is
associated with the following CWEs:
Common Attack Pattern Enumeration and Classification (CAPEC)
Common Attack Pattern Enumeration and Classification
(CAPEC)
stores attack patterns, which are descriptions of the common attributes and
approaches employed by adversaries to exploit the CVE-2017-17677
weaknesses.
Exploit Prediction
EPSS is a daily estimate of the probability of exploitation activity being observed over the next 30 days.
0.48 }} 0.14%
score
0.73474
percentile